3,314 results
·
44ms
·
Sources: EU EUDAMED, US FDA
Coronary Drug-Eluting Stent
FDA Pre-Market Approval
FDA Class 3
·Synerg Everolimus Eluting Conronary Stent System
Coronary Drug-Eluting Stent
FDA Pre-Market Approval
FDA Class 3
·TAXUS LIBERTE PACLITAXEL-ELUTING CORONARY STENT SYSTEM
Coronary Drug-Eluting Stent
FDA Pre-Market Approval
FDA Class 3
·PROMUS(ELEMENT PLUS/PREMIER) EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM
Coronary Drug-Eluting Stent
FDA Pre-Market Approval
FDA Class 3
·FLEXTOME CUTTING BALLOON
Coronary Drug-Eluting Stent
FDA Pre-Market Approval
FDA Class 3
·RESOLUTE MICROTRAC/RESOLUTE INTEGRITY ZOTAROLIMUS-ELUTING CORONARY STENT SYSTEM
Coronary Drug-Eluting Stent
FDA Pre-Market Approval
FDA Class 3
·ORSIRO Mission Sirolimus Eluting Coronary Stent System
Coronary Drug-Eluting Stent
FDA Pre-Market Approval
FDA Class 3
·EluNIR Ridaforolimus Eluting Coronary Stent System
Coronary Drug-Eluting Stent
FDA Pre-Market Approval
FDA Class 3
·EluNIR-PERL Ridaforolimus Eluting Coronary Stent System
Coronary Drug-Eluting Stent
FDA Pre-Market Approval
FDA Class 3
·ENDEAVOR SPRINT ZOTAROLIMUS-ELUTING CORONARY STENT SYSTEMS
Coronary Drug-Eluting Stent
FDA Pre-Market Approval
FDA Class 3
·TAXUS LIBERTE ATOM PACLITAXEL-ELUTING CORONARY STENT SYSTEM
Coronary Drug-Eluting Stent
FDA Pre-Market Approval
FDA Class 3
·Resolute Onyx Rapid Exchange Zotarolimus-Eluting Coronary Stent System, Resoulute Onyx Over The Wire Zotarolimus-Eluting
Coronary Drug-Eluting Stent
FDA Pre-Market Approval
FDA Class 3
·ENDEAVOR ZOTAROLIMUS-ELUTING CORONARY SYSTEMS
Coronary Drug-Eluting Stent
FDA Pre-Market Approval
FDA Class 3
·TAXUS EXPRESS PACLITAXEL-ELUTING CORONARY STENT SYSTEM
Coronary Drug-Eluting Stent
FDA Pre-Market Approval
FDA Class 3
·TAXUS LIBERTE PACLITAXEL-ELUTING CORONARY SYSTEM
Coronary Drug-Eluting Stent
FDA Pre-Market Approval
FDA Class 3
·Resolute Onyx Coronary Stent System
Coronary Drug-Eluting Stent
FDA Pre-Market Approval
FDA Class 3
·EluNIR Ridaforolimus Eluting Coronary Stent System
Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer
FDA Pre-Market Approval
FDA Class 3
·VENTANA HER2 Dual ISH DNA Probe Cocktail
Coronary Drug-Eluting Stent
FDA Pre-Market Approval
FDA Class 3
·XIENCE PRIME, XIENCE PRIME LL Everolimus Eluting Coronary Stent Systems; XIENCE Xpedition, XIENCE Xpedition SV, XIENCE X
Coronary Drug-Eluting Stent
FDA Pre-Market Approval
FDA Class 3
·Resolute Integrity RX Zotarolimus-Eluting Coronary Stent System
Coronary Drug-Eluting Stent
FDA Pre-Market Approval
FDA Class 3
·XIENCE XPEDITION, XIENCE XPEDITION SV, AND XIENCE XPEDITION LL EVEROLIMUS ELUTING CORONARY STENT SYSTEM